Accelerated Pharma (Accelerated Pharma) Other Long-Term Liabilities : $-0.00 Mil (As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Other Long-Term Liabilities?

Accelerated Pharma's other long-term liabilities for the quarter that ended in Mar. 2017 was $-0.00 Mil.

Accelerated Pharma's quarterly other long-term liabilities increased from Sep. 2016 ($-0.00 Mil) to Dec. 2016 ($-0.00 Mil) but then declined from Dec. 2016 ($-0.00 Mil) to Mar. 2017 ($-0.00 Mil).

Accelerated Pharma's annual other long-term liabilities declined from Dec. 2014 ($0.00 Mil) to Dec. 2015 ($0.00 Mil) and declined from Dec. 2015 ($0.00 Mil) to Dec. 2016 ($-0.00 Mil).

Accelerated Pharma Other Long-Term Liabilities Historical Data

The historical data trend for Accelerated Pharma's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Other Long-Term Liabilities Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Other Long-Term Liabilities

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Other Long-Term Liabilities	Get a 7-Day Free Trial			-	-	-	-	-

Accelerated Pharma Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Accelerated Pharma Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines